iShares Biotechnology ETF (IBB)
NASDAQ: IBB · Real-Time Price · USD
156.49
+2.30 (1.49%)
Oct 20, 2025, 4:00 PM EDT - Market closed
IBB Holdings Information
IBB is an equity ETF with a total of 254 individual holdings. The top holdings are Gilead Sciences stock at 7.82%, Vertex Pharmaceuticals at 7.67%, Amgen at 7.47%, Alnylam Pharmaceuticals at 5.65%, and Regeneron Pharmaceuticals at 5.51%.
Total Holdings
25
Top 10 Percentage
48.76%
Asset Class
Equity
ETF Category
Health
Assets
6.57B
PE Ratio
19.75
Sector Allocation
Top 25 Holdings
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | GILD | Gilead Sciences, Inc. | 7.82% |
2 | VRTX | Vertex Pharmaceuticals Incorporated | 7.67% |
3 | AMGN | Amgen Inc. | 7.47% |
4 | ALNY | Alnylam Pharmaceuticals, Inc. | 5.65% |
5 | REGN | Regeneron Pharmaceuticals, Inc. | 5.51% |
6 | ARGX | argenx SE | 3.39% |
7 | IQV | IQVIA Holdings Inc. | 3.22% |
8 | INSM | Insmed Incorporated | 3.20% |
9 | MTD | Mettler-Toledo International Inc. | 2.58% |
10 | NTRA | Natera, Inc. | 2.24% |
11 | BIIB | Biogen Inc. | 1.95% |
12 | WAT | Waters Corporation | 1.86% |
13 | ONC | BeOne Medicines AG | 1.84% |
14 | UTHR | United Therapeutics Corporation | 1.77% |
15 | INCY | Incyte Corporation | 1.58% |
16 | GMAB | Genmab A/S | 1.40% |
17 | ILMN | Illumina, Inc. | 1.33% |
18 | NBIX | Neurocrine Biosciences, Inc. | 1.26% |
19 | MEDP | Medpace Holdings, Inc. | 1.12% |
20 | IONS | Ionis Pharmaceuticals, Inc. | 1.08% |
21 | EXEL | Exelixis, Inc. | 0.96% |
22 | BMRN | BioMarin Pharmaceutical Inc. | 0.94% |
23 | TECH | Bio-Techne Corporation | 0.89% |
24 | ASND | Ascendis Pharma A/S | 0.84% |
25 | MRNA | Moderna, Inc. | 0.83% |
As of Oct 17, 2025
As of Oct 17, 2025